The use of subjective cognitive complaints for detecting mild cognitive impairment in older adults across cultural and linguistic groups: A comparison of the Cognitive Function Instrument to the Montreal Cognitive Assessment.
diverse culture
mild cognitive impairment
older adults
racial/ethnic minorities
subjective cognitive complaints
Journal
Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
26
07
2022
received:
14
04
2022
accepted:
11
08
2022
pmc-release:
01
05
2024
medline:
15
5
2023
pubmed:
13
10
2022
entrez:
12
10
2022
Statut:
ppublish
Résumé
This pilot study aims to explore the psychometric properties of the Cognitive Function Instrument (CFI) as a measure of subjective cognitive complaints (SCC) and its performance in distinguishing mild cognitive impairment (MCI) from normal control (NC) compared to an objective cognitive screen (Montreal Cognitive Assessment [MoCA]). One hundred ninety-four community-dwelling non-demented older adults with racial/ethnic diversity were included. Unidimensionality and internal consistency of the CFI were examined using factor analysis, Cronbach's alpha, and McDonald's omega. Logistic regression models and receiver operating characteristic (ROC) analysis were used to examine the performance of CFI. The CFI demonstrated adequate internal consistency; however, the fit for a unidimensional model was suboptimal. The CFI distinguished MCI from NC alone or in combination with MoCA. ROC analysis showed comparable performance of the CFI and the MoCA. Our findings support the use of CFI as a brief and easy-to-use screen to detect MCI in culturally/linguistically diverse older adults. What is the key scientific question or problem of central interest of the paper? Subjective cognitive complaints (SCCs) are considered the earliest sign of dementia in older adults. However, it is unclear if SCC are equivalent in different cultures. The Cognitive Function Instrument (CFI) is a 14-item measure of SCC. This study provides pilot data suggesting that CFI is sensitive for detecting mild cognitive impairment in a cohort of older adults with racial/ethnic diversity. Comparing performance, CFI demonstrates comparable sensitivity to the Montreal Cognitive Assessment, an objective cognitive screening test. Overall, SCC may provide a non-invasive, easy-to-use method to flag possible cognitive impairment in both research and clinical settings.
Identifiants
pubmed: 36222321
doi: 10.1002/alz.12804
pmc: PMC10090224
mid: NIHMS1833600
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1764-1774Subventions
Organisme : NIA NIH HHS
ID : P30 AG028741
Pays : United States
Organisme : NIA NIH HHS
ID : L30 AG069159
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG059303
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG061439
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG077649
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066514
Pays : United States
Informations de copyright
© 2022 the Alzheimer's Association.
Références
Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):37-43
pubmed: 22193353
J Int Neuropsychol Soc. 2014 Sep;20(8):836-47
pubmed: 25156329
Alzheimers Res Ther. 2018 Aug 7;10(1):76
pubmed: 30081935
Neuropsychol Rev. 2016 Dec;26(4):376-393
pubmed: 27714573
J Alzheimers Dis. 2017;60(2):427-437
pubmed: 28854503
J Geriatr Psychiatry Neurol. 2022 Jul;35(4):586-593
pubmed: 34378450
Eur Psychiatry. 2008 Aug;23(5):321-30
pubmed: 18434102
JAMA Neurol. 2013 Mar 1;70(3):374-82
pubmed: 23599941
Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):105-14
pubmed: 26142292
Am J Geriatr Psychiatry. 2015 Sep;23(9):906-14
pubmed: 25441053
J Alzheimers Dis. 2016;51(4):1145-55
pubmed: 26923008
Alzheimers Dement. 2014 Nov;10(6):844-52
pubmed: 24798886
Value Health. 2017 Apr;20(4):533-541
pubmed: 28407994
JAMA. 1997 Oct 22-29;278(16):1349-56
pubmed: 9343467
Alzheimers Dement (Amst). 2021 Feb 05;13(1):e12144
pubmed: 33598528
Int J Geriatr Psychiatry. 2019 Feb;34(2):233-242
pubmed: 30370616
Sleep Med Rev. 2020 Apr;50:101250
pubmed: 31881487
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
Neural Plast. 2016;2016:8501693
pubmed: 26881137
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Appl Neuropsychol Adult. 2021 Sep 23;:1-8
pubmed: 34554020
Int J Geriatr Psychiatry. 2021 Nov;36(11):1739-1747
pubmed: 34216392
Dement Geriatr Cogn Dis Extra. 2015 Mar 06;5(1):85-95
pubmed: 25873930
Alzheimers Dement. 2008 Mar;4(2):96-109
pubmed: 18631955
Expert Rev Mol Med. 2016 May 30;18:e11
pubmed: 27237222
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Neurol Sci. 2022 Jan;43(1):113-124
pubmed: 34750686
Science. 1993 Aug 13;261(5123):921-3
pubmed: 8346443
Ann Intern Med. 2003 Jun 3;138(11):927-37
pubmed: 12779304
Neurology. 2006 Sep 12;67(5):834-42
pubmed: 16966547
Am J Geriatr Pharmacother. 2008 Jun;6(2):100-18
pubmed: 18675769
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Neurology. 2014 Oct 7;83(15):1359-65
pubmed: 25253756
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Br J Psychol. 2014 Aug;105(3):399-412
pubmed: 24844115
J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86
pubmed: 26402085
Int J Geriatr Psychiatry. 2020 Mar;35(3):261-269
pubmed: 31650623
J Alzheimers Dis. 2017;58(3):789-801
pubmed: 28482634
J Geriatr Psychiatry Neurol. 2011 Mar;24(1):33-8
pubmed: 21156989
Alzheimers Dement (N Y). 2018 Sep 06;4:444-449
pubmed: 30258973
Ann Fam Med. 2019 Sep;17(5):412-418
pubmed: 31501202
Aging Ment Health. 2019 Oct;23(10):1300-1306
pubmed: 30449144
Alzheimers Dement. 2019 Feb;15(2):292-312
pubmed: 30555031
Mayo Clin Proc. 2019 Aug;94(8):1516-1523
pubmed: 31280871
Alzheimers Dement. 2015 Mar;11(3):332-84
pubmed: 25984581
Value Health. 2008 May-Jun;11(3):509-21
pubmed: 18179659
J Alzheimers Dis. 2021;81(2):545-555
pubmed: 33814436
Alzheimers Dement (Amst). 2015 Mar 1;1(1):33-40
pubmed: 25938132
Annu Rev Clin Psychol. 2017 May 8;13:369-396
pubmed: 28482688
Alzheimers Dement. 2014 Jan;10(1):76-83
pubmed: 23375567
J Prev Alzheimers Dis. 2021;8(3):257-262
pubmed: 34101781
JAMA Neurol. 2015 Apr;72(4):446-54
pubmed: 25706191
J Alzheimers Dis. 2014;42 Suppl 4:S551-9
pubmed: 25171716
Arch Neurol. 2001 Dec;58(12):1985-92
pubmed: 11735772
Int J Geriatr Psychiatry. 2005 Oct;20(10):911-8
pubmed: 16163741
JAMA Neurol. 2020 Jun 1;77(6):735-745
pubmed: 32250387
Alzheimers Dement. 2017 Mar;13(3):296-311
pubmed: 27825022
J Alzheimers Dis. 2018;64(2):643-655
pubmed: 29945351
Neurology. 1993 Aug;43(8):1467-72
pubmed: 8350998
J Am Geriatr Soc. 2013 Dec;61(12):2181-2185
pubmed: 24320735
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Pharmacol Rep. 2015 Apr;67(2):195-203
pubmed: 25712639
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S170-8
pubmed: 17135810
J Alzheimers Dis. 2016 Oct 4;54(3):1135-1146
pubmed: 27567852
Curr Alzheimer Res. 2009 Aug;6(4):324-30
pubmed: 19689230
Lancet Neurol. 2020 Mar;19(3):271-278
pubmed: 31958406